4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-26-003004
Chief Executive Officer bought 9,804 shares at an average $2.07 ($20,246)
- Chief Executive Officer disposed of 50,462 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Mor George Adi · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Purchase : show line 1 in the form | −4,878 | $2.05 | $10,000 | 134,205 | D |
| 2026-05-29 | Purchase : show line 2 in the form | −4,926 | $2.08 | $10,246 | 139,131 | D |
| 2026-05-29 | Other disposition : show line 3 in the form | −31,712 | 31,712 | D | ||
| 2026-05-29 | Other disposition : show line 4 in the form | −18,750 | 18,750 | D | ||
| Open-market purchases · 9,804 sh · avg $2.07 · $20,246 | ||||||
Loading xslF345X06/ownership.xml…